The recent landscape of RSV vaccine research
Respiratory syncytial virus (RSV) causes a significant burden of acute respiratory illness across all ages, particularly for infants and older adults. Infants, especially those born prematurely or with underlying health conditions, face a high risk of severe RSV-related lower respiratory tract infec...
Saved in:
Main Authors: | Karen Kelleher, Nadisha Subramaniam, Simon B. Drysdale |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Vaccines and Immunotherapy |
Online Access: | https://doi.org/10.1177/25151355241310601 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
by: Erdal Eroglu, et al.
Published: (2016-01-01) -
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01) -
Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study
by: Malik Sallam, et al.
Published: (2025-01-01) -
DS2 designer pre-fusion F vaccine induces strong and protective antibody response against RSV infection
by: Yiling Yang, et al.
Published: (2024-12-01) -
The Use of Albuterol in Young Infants Hospitalized with Acute RSV Bronchiolitis
by: Michael T. Del Vecchio, et al.
Published: (2012-01-01)